Merck Reshapes Leadership As HIV And RSV Prospects Take Center Stage

Merck (NYSE:MRK) announced a major reorganization of its Human Health business into two global units focused on Oncology and ...

Merck KGaA sees earnings drop on currency effects, MS drug

By Ludwig Burger and Patricia Weiss FRANKFURT, March 5 (Reuters) - Germany's Merck KGaA projected 2026 adjusted operating ...

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK) and Opus Genetics (IRD)

According to TipRanks.com, Hector is a 4-star analyst with an average return of 7.0% and a 61.2% success rate. Hector covers the Healthcare sector, focusing on stocks such as Roche Holding AG, Sanofi, ...
PharmiWeb

Merck Evolves Human Health Operating Structure to Support Portfolio Execution

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today highlighted steps to evolve the structure of its Human Health organization to ensure strong commercial execution of ...
Business Wire

Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent

RAHWAY, N.J. & SAN DIEGO, Calif.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Cidara Therapeutics, Inc. (Nasdaq: CDTX) (“Cidara”), a biotechnology ...
WFMZ-TV

Merck plans to cut billions of dollars, jobs, by end of 2027

Merck headquarters in Rahway, NJ. RAHWAY, N.J. – You can’t say you weren’t warned. Last year Merck, the giant pharmaceutical company with multiple facilities in eastern Pennsylvania and New Jersey, ...
Morningstar

Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced a historic agreement with the Trump administration to ensure its prescription medicines are both accessible and ...

Synthekine Announces Clinical Trial Collaboration with Merck to Evaluate STK-012 In Combination with Keytruda® (Pembrolizumab) and Chemotherapy in Ongoing Randomized Phase 2 ...

Synthekine Inc., an engineered cytokine therapeutics company, today announced that it has entered into a clinical trial collaboration and supply agreement with Merck (known as MSD outside of the ...

Analysts Have Conflicting Sentiments on These Healthcare Companies: Cogent Biosciences (COGT), Aquestive Therapeutics (AQST) and Merck & Company (MRK)

According to TipRanks.com, Gould is a 4-star analyst with an average return of 6.6% and a 53.0% success rate. Gould covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, ...
Business Wire

Merck to Participate in the 7th Annual Evercore ISI HealthCONx Conference

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Dr. Eliav Barr, senior vice president, head of global clinical development ...
KRQE Blogs

Merck spends $10 billion for Verona, gaining access to its COPD medication

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Pharmaceutical giant Merck is buying Verona ...